Leptin levels in patients with Parkinson's disease: A systematic review and meta-analysis
Leptin levels in patients with Parkinson's disease: A systematic review and meta-analysis
نویسندگان: سما رهنمایان , مژگان میرغفوروند , آرزو فتحعلی زاده , الناز فرامرزی , آنیتا ریحانی فرد , عطا محمودپور , سروین سنایی اسکویی
کلمات کلیدی: Parkinson's disease,Leptin,Systematic review,Meta-analysis
نشریه: 0 , 2021 , 41 , 2021
| نویسنده ثبت کننده مقاله |
سروین سنایی اسکویی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات علوم اعصاب |
| کد مقاله |
75033 |
| عنوان فارسی مقاله |
Leptin levels in patients with Parkinson's disease: A systematic review and meta-analysis |
| عنوان لاتین مقاله |
Leptin levels in patients with Parkinson's disease: A systematic review and meta-analysis |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
Clinical Nutrition ESPEN |
| نوع مقاله |
Systematic Review Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Summary
Background and aims
The exact mechanism of Parkinson's disease (PD) is not fully understood yet, but it is suggested that inflammation is one of its contributing factors. Among several inflammatory factors, adipokines, especially leptin may have a great role in this mechanism; since it is not only causing inflammation, but it can also play other roles in the body that may contribute to the symptoms described for PD. Regarding the contradictions in the association of serum leptin levels with Parkinson's disease, a systematic review and meta-analysis was performed to have a more accurate estimation of this relationship.
Methods
Published literature was obtained by searching PubMed, Embase, Cochrane Library, Scopus, Ovid, ProQuest and Google Scholar. Random-effect model analysis was used to calculate pooled standard mean difference (SMD) with 95% confidence interval (CI). Heterogeneity was tested with the heterogeneity statistic Q and quantified using I2. Newcastle-Ottawa scale was used to assess the study quality.
Results
Six studies including a total number of 198 PD patients and 182 controls were finally included in the meta-analysis. Serum leptin levels in PD patients were non-significantly lower than those in control group (SMD = −0.40 ng/ml, 95% CI -2.33–1.53). Subgroup analyses revealed that serum leptin levels of PD patients and controls in either females or males didn't show any significant difference.
Conclusions
This meta-analysis revealed that leptin level doesn't show any significant difference between PD patients and healthy controls, even when taking the participants' gender into consideration. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| pdf.pdf | 1399/11/15 | 866980 | دانلود |